Language selection

Search

2012-09-12 - Male - 23 Years old

462659

Adverse reaction report number 462659
Latest AER version number 0
Market authorization holder AER number ALL1201301043
Initial received date 2012-09-12
Latest received date 2012-09-12
Age 23 Years
Gender Male
Weight N/A
Type of report Spontaneous
Reporter type Consumer Or Other Non Health Professional
Source of report Community
Report outcome Recovering/resolving
Serious report? No

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XR 30MGCAPSULE, EXTENDED RELEASESuspectOral30 Milligram1 every 1 Day(s) Attention deficit/hyperactivity disorder

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Agitation
Date modified: